HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TNF-α-Induce Protein 8-Like 1 Inhibits Hepatic Steatosis, Inflammation, and Fibrosis by Suppressing Polyubiquitination of Apoptosis Signal-Regulating Kinase 1.

AbstractBACKGROUND AND AIMS:
Characterized by hepatocyte steatosis, inflammation, and fibrosis, NASH is a complicated process that contributes to end-stage liver disease and, eventually, HCC. TNF-α-induced protein 8-like 1 (TIPE1), a new member of the TNF-α-induced protein 8 family, has been explored in immunology and oncology research; but little is known about its role in metabolic diseases.
APPROACH AND RESULTS:
Here, we show that hepatocyte-specific deletion of TIPE1 exacerbated diet-induced hepatic steatosis, inflammation, and fibrosis as well as systemic metabolic disorders during NASH pathogenesis. Conversely, hepatocyte-specific overexpression of TIPE1 dramatically prevented the progression of these abnormalities. Mechanically, TIPE1 directly interacted with apoptosis signal-regulating kinase 1 (ASK1) to suppress its TNF receptor-associated factor 6 (TRAF6)-catalyzed polyubiquitination activation upon metabolic challenge, thereby inhibiting the downstream c-Jun N-terminal kinase and p38 signaling pathway. Importantly, dramatically reduced TIPE1 expression was observed in the livers of patients with NAFLD, suggesting that TIPE1 might be a promising therapeutic target for NAFLD and related metabolic diseases.
CONCLUSIONS:
TIPE1 protects against hepatic steatosis, inflammation, and fibrosis through directly binding ASK1 and restraining its TRAF6-catalyzed polyubiquitination during the development of NASH. Therefore, targeting TIPE1 could be a promising therapeutic approach for NAFLD treatment.
AuthorsHong Wu, Xiaolei Xu, Ancheng Zheng, Weina Wang, Li Mei, Yue Chen, Shasha Sun, Liujun Jiang, Yutao Wu, Yijiang Zhou, Min Zheng, Qishan Chen
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 74 Issue 3 Pg. 1251-1270 (09 2021) ISSN: 1527-3350 [Electronic] United States
PMID33713358 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 by the American Association for the Study of Liver Diseases.
Chemical References
  • Intracellular Signaling Peptides and Proteins
  • TIPE1 protein, mouse
  • TNFAIP8L1 protein, human
  • Polyubiquitin
  • MAP Kinase Kinase Kinase 5
Topics
  • Adult
  • Aged
  • Animals
  • Diet, High-Fat
  • Down-Regulation
  • Fatty Liver (genetics, metabolism, pathology)
  • Female
  • Humans
  • Inflammation
  • Intracellular Signaling Peptides and Proteins (genetics, metabolism)
  • Liver Cirrhosis (genetics, metabolism, pathology)
  • MAP Kinase Kinase Kinase 5 (metabolism)
  • Male
  • Mice, Knockout
  • Mice, Transgenic
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease (genetics, metabolism)
  • Polyubiquitin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: